These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8218783)

  • 61. [Echocardiographic changes in hypertensive patients treated with a fixed combination of metoprolol and chlorthalidone].
    Vincenzi M; De Dominicis E; Lazzaretto R; Mattiello M; Onza I
    Minerva Cardioangiol; 1986 Oct; 34(10):625-31. PubMed ID: 3808330
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effects of a nifedipine-acebutolol combination in the treatment of patients with essential arterial hypertension].
    Strano A; Novo S; Licata G; Salerno L; Pinto A; Favi G; Botindari G
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II13-8. PubMed ID: 7170403
    [No Abstract]   [Full Text] [Related]  

  • 63. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 64. [Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
    Campana C; Ferrario M; Tondi C; Montemartini C
    Minerva Cardioangiol; 1985 Oct; 33(10):643-7. PubMed ID: 3908972
    [No Abstract]   [Full Text] [Related]  

  • 65. [Nifedipine-captopril combination in the treatment of refractory arterial hypertension].
    Cosenzi A; Franca G; Piemontesi AM; Sancandi M; Bellini G
    G Clin Med; 1986 Dec; 67(5-6):297-300. PubMed ID: 3301489
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of hypertension with a combination of beta receptor blockers and diuretics (Trasitensin retard)].
    Mertz DP
    MMW Munch Med Wochenschr; 1979 Feb; 121(7):251-2. PubMed ID: 105287
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 68. [Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
    Budriesi N; Adalio G; Zamboni A; Turina MC
    G Clin Med; 1986 Apr; 67(2):109-13. PubMed ID: 3792715
    [No Abstract]   [Full Text] [Related]  

  • 69. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 70. [Use of metoprolol and atenolol, singly or in combination with a diuretic, in the treatment of arterial hypertension].
    Centritto V
    Boll Soc Ital Cardiol; 1980; 25(5):451-7. PubMed ID: 7284149
    [No Abstract]   [Full Text] [Related]  

  • 71. [Prazosin in moderate or severe essential arterial hypertension not controlled with chlorthalidone. A multicenter study].
    Saldanha RV; Macruz R; Santana PC; de Lima JJ; Zalc S; Pileggi F
    Arq Bras Cardiol; 1983 Jun; 40(6):433-8. PubMed ID: 6667153
    [No Abstract]   [Full Text] [Related]  

  • 72. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
    [No Abstract]   [Full Text] [Related]  

  • 73. [Open study to evaluate the efficacy and tolerance of prolonged-action nifedipine in the treatment of mild to moderate essential arterial hypertension].
    Med Clin (Barc); 1988 Oct; 91(13):493-5. PubMed ID: 3226200
    [No Abstract]   [Full Text] [Related]  

  • 74. [Nifedipine and molsidomine treatment of circulatory insufficiency in elderly patients with hypertension].
    Degtiarev OA; Ivanov AI; Sotskova TV; Mikerova TM
    Sov Med; 1990; (4):57-9. PubMed ID: 2374974
    [No Abstract]   [Full Text] [Related]  

  • 75. [A comparison of the effects of nifedipine and nifedipine retard on blood pressure reduction before and after treadmill exercise].
    Tsai CH; Wu TC
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Sep; 42(3):185-90. PubMed ID: 3224318
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
    Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
    Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Plasma levels of nifedipine (Adalat Retard) in aged hypertensive patients].
    Schnapp P; Kahay J; Baricic P; Capková H
    Cesk Farm; 1987 Feb; 36(1):29-31. PubMed ID: 3568156
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 79. A general practice trial of antihypertensive therapy comparing a combination of nicardipine and chlorthalidone with atenolol and chlorthalidone.
    Douglas-Jones AP; Coxhead PF
    Br J Clin Pract; 1986 Mar; 40(3):100-4. PubMed ID: 3518779
    [No Abstract]   [Full Text] [Related]  

  • 80. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
    Galletti F; Barba G; Nardecchia A; Strazzullo P; Scagliusi P; Pirrelli A; Mancini M
    J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.